SRC and renal carcinoma: Wei et al. demonstrated that nobiletin could induce cell cycle arrest in the G0/G1 phase and promote apoptosis via the SRC/AKT/STAT3/YY1AP1 pathway in human renal carcinoma cells (Wei et al., 2019).